+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mexico - Healthcare, Regulatory and Reimbursement Landscape

  • PDF Icon

    Report

  • 167 Pages
  • December 2021
  • Region: Mexico
  • GlobalData
  • ID: 2881896
Description Jump to:
The publisher, the industry analysis specialist, has released its latest report “Mexico - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Mexico. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

In terms of revenue, Mexico is the eleventh largest pharmaceutical market in the world and the second largest in Latin America, after Brazil. With a large and rising middle-class population, a favorable environment for private sector investment, and a rise in demand for healthcare services, Mexico is developing as one of the most promising destinations for pharmaceutical investments. Mexico is also home to 14 of the top 15 multinational corporations, establishing itself as one of the world's major industrial hubs. Mexico is a key manufacturer of high-tech medicines that include but are not limited to antibiotics, anti-inflammatories, and cancer therapies. The Mexican pharmaceutical market, in terms of US dollars, increased from $11.52B in 2013 to $21.48B in 2020, at a Compound Annual Growth Rate (CAGR) of 9%. The market is expected to grow at a 9% CAGR from 2021 to 2025, reaching $33.04B in 2025. In 2016, the medical devices market in Mexico was worth $8.65B, which increased at a CAGR of 4.6% to $10.83B in 2021. From 2022 to 2027, it is expected to grow at a CAGR of 3.41%, reaching $12.45B in 2027

Scope


The report provides information on the healthcare, regulatory, and reimbursement landscape in Mexico, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Sanofi, Pfizer, Boehringer Ingelheim, and Genomma Lab.
  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Stryker, Boston Scientific, and Biomerica.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the Mexican healthcare market.

Reasons to Buy


This report will enhance your decision-making capability by allowing you to:
  • Develop business strategies by understanding the trends shaping and driving Mexican healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Mexican healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1. Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Mexico Healthcare Market
2.3 Key Highlights: Healthcare Startups in Mexico
2.4 Key Events: Healthcare Industry, Mexico, 2015-2021
2.5 Key Events: Mexico Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Mexico, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Mexico
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas - Mexico
3.7 COVID-19 Epidemiology, Mexico
3.8 COVID-19 Impact and Developments, Mexico
3.9 COVID-19 Impact and Developments in the Healthcare Market, Mexico
3.10 COVID-19 Clinical Trials Landscape, Mexico
3.11 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Mexico, 2019-2021
6.2 Deal Analysis: Medical Device Market, Mexico, 2019-2021
7. HealthTech Landscape
7.1 HealthTech Landscape, Mexico
7.2 HealthTech Deals Landscape, Mexico
7.3 Key HealthTech Deals, Mexico
7.4 Adoption of Technology in Healthcare, Mexico
7.5 Digital Regulations, Mexico
7.6 HealthTech Landscape: Benefits and Risks, Mexico
8. Market Access
8.1 Overview of Healthcare System, Mexico
8.2 Reimbursement Process, Mexico
8.3 Overview of Insurance Providers, Public Insurance, Mexico
8.4 Overview of Insurance Providers, Private Insurance, Mexico
8.5 Out-of-Pocket Spending and Pharmaceutical Price Index, Mexico
8.6 Pricing Policies, Mexico
8.7 Regulatory Landscape, Mexico
8.7.1 Marketing Authorization for Pharmaceutical Products, Mexico
8.7.2 Marketing Authorization for Generic Medicines, Mexico
8.7.3 Marketing Authorization for Biologics and Biosimilars, Mexico
8.7.4 Marketing Authorization for Medical Devices, Mexico
8.7.5 Pharmaceutical Exports and Imports Regulations, Mexico
8.7.6 Intellectual Property Rights, Mexico
8.7.7 Intellectual Property Rights, Patent, Mexico
8.7.8 Intellectual Property Rights, Trademark, Mexico
8.7.9 Clinical Trial Regulations, Mexico
8.7.10 Pharmaceutical Clinical Trials Landscape, Mexico
8.7.11 Medical Devices Clinical Trials Landscape, Mexico
8.7.12 Pharmacy License Regulations, Mexico
8.7.13 Pharmaceutical Advertising Regulations, Mexico
8.7.14 Labeling and Packaging Regulations, Mexico
9. Country Healthcare Landscape
9.1 Mexican Healthcare Policy Highlights
9.2 Healthcare Facilities, Mexico
9.3 Healthcare Parameters, Mexico
9.4 Life Expectancy and Immunization Rate, Mexico
9.5 Environmental Health, Mexico
9.6 Healthcare Personnel, Mexico
9.7 Disease Burden, Mexico
9.8 Healthcare Expenditure, Mexico
10 Trade Associations, Mexico11 Trade Fairs, Mexico12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About The Publisher
13.4 Contact The Publisher
13.5 Disclaimer
List of Tables
Table 1: Approved Biosimilars, Mexico, 2019
Table 2: COVID-19 Indicators (Number of Cases), Mexico and Global, 2021
Table 3: Phases of Contingency, Plan for the Return to the New Normality, COVID-19, Mexico, 2020
Table 4: Travel Restrictions Imposed During COVID-19, Mexico, 2020-2021
Table 5: Available COVID-19 Vaccines, Mexico, 2020-2021
Table 6: Medical Devices Market, Mexico, Major Segments ($B), 2020
Table 7: Hospital Supplies Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 8: General Surgery Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 9: Orthopedic Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 10: Cardiovascular Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 11: Diabetes Care Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 12: Healthcare Services Covered by INSABI Versus. SP, Mexico, 2020
Table 13: Medical Devices Classification, Mexico, 2020
Table 14: Requirements for Medical Device Registration, Mexico, 2020
Table 15: Patent Application Fee, Mexico, 2021
Table 16: Trademark Application Fee, Mexico, 2021
Table 17: Trade Fairs, Mexico
List of Figures
Figure 1: Pharmaceutical Market, Mexico, Revenue ($B), 2013-2020
Figure 2: Medical Devices Market, Mexico, Revenue ($B), 2016-2021
Figure 3: Healthcare Start-Ups in Mexico, 2020
Figure 4: Country Profile, Mexico, 2020
Figure 5: Pharmaceutical Market, Mexico, Revenue ($B), 2013-2020
Figure 6: Pharmaceutical Market, Mexico, Revenue Forecast ($B), 2021-2025
Figure 7: Objectives and Priority Strategies of the Sectorial Health Program, Mexico, 2019-2024
Figure 8: Pharmaceutical Exports ($B), Mexico, 2013-2020
Figure 9: Top Export Partners, Mexico, 2020
Figure 10: Pharmaceutical Imports ($B), Mexico, 2013-2020
Figure 11: Top Import Partners, Mexico, 2020
Figure 12: Pharmaceutical Distribution Channels, Mexico, 2019
Figure 13: OTC Medicines Market, Revenue ($B), Mexico, 2013-2020
Figure 14: OTC Medicines Market, Major Distribution Channels ($M), Mexico, 2020
Figure 15: OTC Medicines Market, Major Categories ($M), Mexico, 2020
Figure 16: Major Therapeutic Areas by Pharmaceutical Sales ($M), Mexico, 2017-2019
Figure 17: COVID-19 (Number of Cases), Mexico, 2020-2021
Figure 18: COVID-19 (Number of Deaths), Mexico, 2020-2021
Figure 19: Traffic Lights Coding System, Plan for the Return to the New Normality , COVID-19, Mexico, 2020
Figure 20: COVID-19 Stringency Index, Mexico, 2020-2021
Figure 21: Containment and Health Index, COVID-19 , Mexico, 2020-2021
Figure 22: COVID-19 Fiscal Stimulus Packages, Mexico, 2020-2021
Figure 23: COVID-19 Vaccine Doses Administration, Number of Vaccine Doses Administered, Mexico, 2021
Figure 24: Stages of COVID-19 Vaccination, National Vaccination Plan, Mexico, 2021
Figure 25: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Mexico, 2020-2021
Figure 26: Top COVID-19 IVD Products by Device Class (Number of Available Marketed Products), Mexico, 2020-2021
Figure 27: Top COVID-19 IVD Products by Equipment Type (Number of Available Marketed Products), Mexico, 2020-2021
Figure 28: Top COVID-19 Anesthesia and Respiratory Devices Products by Equipment Type (Number of Available Marketed Products), Mexico, 2020-2021
Figure 29: COVID-19 Clinical Trials Sponsors by Count, Mexico, 2020-2021
Figure 30: COVID-19 Clinical Trials Count by Phase, Mexico, 2020-2021
Figure 31: COVID-19 Clinical Trials Count by Trial Status, Mexico, 2020-2021
Figure 32: Medical Devices Market, Mexico, Revenue ($B), 2016-2021
Figure 33: Medical Devices Market, Mexico, Revenue Forecast ($B), 2022-2027
Figure 34: Medical Devices Market, Mexico, Major Segments (%), 2020
Figure 35: Hospital Supplies Market, Mexico, Revenue ($B), 2017-2025
Figure 36: Hospital Supplies Market, Mexico, Market Share of Major Players (%), 2020
Figure 37: General Surgery Market, Mexico, Revenue ($M), 2017-2025
Figure 38: General Surgery Market, Mexico, Market Share of Major Players (%), 2020
Figure 39: Orthopedic Devices Market, Mexico, Revenue ($M), 2017-2025
Figure 40: Orthopedic Devices Market, Mexico, Market Share of Major Players (%), 2020
Figure 41: Cardiovascular Devices Market, Mexico, Revenue ($M), 2017-2025
Figure 42: Cardiovascular Devices Market, Mexico, Market Share of Major Players (%), 2020
Figure 43: Diabetes Care Devices Market, Mexico, Revenue ($M), 2017-2025
Figure 44: Diabetes Care Devices Market, Mexico, Market Share of Major Players (%), 2020
Figure 45: Diagnostics Market, Mexico, Revenue ($M), 2015-2020
Figure 46: Diagnostics Market, Mexico, Revenue Forecast ($M), 2021-2025
Figure 47: Medical Devices Market, Revenue ($B) of Major Companies, Mexico, 2020
Figure 48: Deal Value and Deal Count, Pharmaceutical Market, Mexico, 2019-2021
Figure 49: Deal Value and Deal Count Subtypes, Pharmaceutical Market, Mexico, 2019-2021
Figure 50: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Mexico, 2019-2021
Figure 51: Top Therapy Areas by Deal Value ($M), Pharmaceutical Market, Mexico, 2019-2021
Figure 52: M&A Deals by Quarter, Pharmaceutical Market, Mexico, 2019-2021 (by Value and by Number)
Figure 53: Top Therapy Areas by Deal Count, Pharmaceutical Market, Mexico, 2019-2021
Figure 54: Deal Value and Deal Count, Medical Devices Market, Mexico, 2019-2021
Figure 55: Deal Value and Deal Count Subtypes, Medical Devices Market, Mexico, 2019-2021
Figure 56: Deal Value and Deal Count, Quarterly, Medical Devices Market, Mexico, 2019-2021
Figure 57: Top Equipment Sectors by Deal Value ($M), Medical Devices Market, Mexico, 2019-2021
Figure 58: M&A Deals by Quarter, Medical Devices Market, Mexico, 2019-2021 (by Value and by Number)
Figure 59: Top Equipment Sectors by Deal Count, Medical Devices Market, Mexico, 2019-2021
Figure 60: VF Deals by Quarter, Medical Devices Market, Mexico, 2019-2021 (by Value and by Number)
Figure 61: Objectives of the Digital Policy in the Federal Public Administration, National Digital Strategy, Mexico, 2021-2024
Figure 62: Objectives of the Digital Social Policy, National Digital Strategy, Mexico, 2021-2024
Figure 63: Deal Value ($M), HealthTech, Mexico, 2015-2021
Figure 64: Deal Count (Number of Deals), HealthTech, Mexico, 2015-2021
Figure 65: Features available on COVID Radar App, Mexico, 2021
Figure 66: Major Functions of CENETEC - Salud, Mexico, 2021
Figure 67: Organization of Healthcare System, Mexico, 2020
Figure 68: Reimbursement Process, Stage I, Mexico, 2020
Figure 69: Reimbursement Process, Stage II, Mexico, 2020
Figure 70: Reimbursement Process, Stage III, Mexico, 2020
Figure 71: Financial Flows for the Payment of Health Providers, Mexico, 2020
Figure 72: Out-of-Pocket Spending ($ per Capita), Mexico, 2013-2020
Figure 73: Annual Rate of Change in Health and Welfare Services Price Index (% Change Accumulated in the Year), Mexico, 2013-2019
Figure 74: Principles of Fair and Equitable Public Management, UNOPS, Mexico, 2020
Figure 75: Marketing Authorization of Pharmaceutical Products, Mexico, 2020
Figure 76: Patent Approval Process, Mexico, 2021
Figure 77: Trademark Registration Process, Mexico, 2021
Figure 78: Pharmaceutical Clinical Trials Count by Trial Status, Mexico, 2020-2021
Figure 79: Pharmaceutical Clinical Trials Count by Therapy Area, Mexico, 2020-2021
Figure 80: Pharmaceutical Clinical Trials Count by Phase, Mexico, 2020-2021

Related Topics

Related Reports

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets - Product Image

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

  • Report
  • 157 Pages
  • Global
From
Healthcare BPO Market Report by Payer Service, Provider Service, Pharmaceutical Service, and Region 2024-2032 - Product Image

Healthcare BPO Market Report by Payer Service, Provider Service, Pharmaceutical Service, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
Behavioral Health Market By Disorder, By Service, By Age Group: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Behavioral Health Market By Disorder, By Service, By Age Group: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 283 Pages
  • Global
From
Healthcare Reimbursement Market by Claim, Payer, Service Provider - Global Forecast 2025-2030 - Product Image

Healthcare Reimbursement Market by Claim, Payer, Service Provider - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Medical Billing Market by Offerings, Type, Deployment, Application, End-User - Global Forecast 2025-2030 - Product Image

Medical Billing Market by Offerings, Type, Deployment, Application, End-User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.